Q3 2024 Hester Biosciences Ltd Earnings Call Transcript
Key Points
- Hester Biosciences Ltd (BOM:524669) reported a 10% increase in stand-alone revenue and a 13% increase in consolidated revenue for the 9 months of FY '24.
- The Poultry Healthcare division experienced an 8% growth, marking a positive trend after 7 quarters of decline.
- The Petcare division demonstrated an impressive overall growth of 91% over the 9 months of FY '24.
- The company introduced a new product, CurX LA, as a substitute for discontinued products, showing proactive measures to address regulatory challenges.
- Hester Biosciences Ltd (BOM:524669) maintained an overall gross profit margin of 67% in Q3 FY '24.
- Stand-alone revenue for Q3 FY '24 decreased by 7%, and consolidated revenue saw an 11% decrease.
- The Animal Healthcare division observed an 18% decline in sales during Q3 FY '24 compared to the corresponding quarter.
- The discontinuation of two brands, CurX Injection and iSumovet, due to regulatory changes, negatively impacted sales.
- Hester Nepal reported a net loss of INR 0.94 crore in Q3 FY '24, despite generating INR 0.8 crore in revenue.
- Hester Africa experienced an overall loss of INR 3.6 crores in Q3 and INR 13 crores over the 9 months of FY '24, primarily due to unmet sales targets and fixed costs.
Good afternoon, ladies and gentlemen. Good day and welcome to Q3 FY '24 Earnings Conference Call of Hester Biosciences hosted by ICICI Securities. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Kashish Thakur from ICICI Securities. Please go ahead, sir.
Good afternoon, everyone. I welcome you all to Hester Biosciences Q3 and 9 months FY '24 Earnings Conference Call. So today, from Hester Biosciences we have the senior management with us, Mr. Rajiv Gandhi, CEO and Managing Director; Ms. Priya Gandhi, Executive Director; and Mr. Nikhil Jhanwar, CFO, on this call. I thank the management of Hester Biosciences for giving ICICI Securities this opportunity to host this call.
And now I hand over the call to Ms. Priya Gandhi. Over to you, ma'am.
Thank you. Good afternoon, everyone. This is Priya Gandhi, Executive Director at Hester
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
